Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
LifeArc Ventures, established in 2017, operates as part of LifeArc, a self-financing medical research charity based in the UK. The firm focuses on early-stage investments in science-led companies within the life sciences sector, managing a portfolio of 15 companies. Their investment strategy emphasizes translational scientific research and companies with protectable intellectual property.
LifeArc Ventures primarily invests in Seed and Series A funding rounds, with potential for significant follow-on investments. The firm targets sectors such as therapeutics, HealthTech, and medical devices, emphasizing companies with outstanding scientific founders and a strong UK science base, while remaining open to global opportunities.
Notable portfolio companies include Exciva, developing therapies for Alzheimer's disease; GlycoEra, focused on protein degraders for autoimmune diseases; and Fluid Biomed, commercializing a polymer-based brain stent for aneurysms. Other companies include AviadoBio, creating transformative medicines for neurodegenerative disorders, and Cumulus Neuroscience, which monitors CNS diseases with a digital biomarker platform.
Submit your pitch through their form at lifearcventures.com or email ventures@lifearc.org with your deck.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.